Septerna (SEPN) Fundamentals 2026 — Revenue Analysis | SniperIQ
Septerna (SEPN) is a US-listed Healthcare company in Biotechnology with a market capitalization of
3.35 on the NASDAQ. This SniperIQ fundamentals page covers Septerna's valuation, profitability (net margin -49.9%), revenue ($46M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Septerna's market cap?
Septerna (SEPN) has a market capitalization of approximately
3.35 on the NASDAQ. Market cap moves with the live share price.What is Septerna's P/E ratio?
Septerna's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 3.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Septerna?
Septerna runs a net profit margin of -49.9%, a gross margin of 99.4%, and an operating margin of -77.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Septerna generate?
Septerna reported revenue of $46M for fiscal year 2025, with net income of -$49M and earnings per share (EPS) of -1.1. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Septerna pay a dividend?
Septerna does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Septerna financially healthy?
Septerna carries a debt-to-equity ratio of 0.06x and a current ratio of 4.71x, with a market beta of 3.50. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Septerna a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Septerna (SEPN) the key facts are: market cap
Track Septerna's full fundamentals live
Get Septerna's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.